It has been reported that excess SEMA3A expression may accelerate kidney injury in a variety of kidney diseases via the JNK or Akt signaling pathway [42,43,44,45,46], suggesting that targeting SEMA3A signaling may be a potential therapy against kidney injury. Here, MAPK8 is linked to kidney disorder.